<DOC>
	<DOC>NCT02456077</DOC>
	<brief_summary>The purpose of this study is to determine if a multimodal Human Papillomavirus (HPV) immunization program carried out in pediatric and family medicine practices would be more effective in improving adolescent patients' HPV immunization rates than the usual care provided to adolescents in pediatric and family medicine practices.</brief_summary>
	<brief_title>Strengthening Physician Communication About HPV Vaccines</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria for immunization rate assessment: 1. 9 years of age or older when presenting for care 2. Patients who present for care one year prior to the start of the intervention and up to two years after the start of the intervention 1. Less than 9 years of age when presenting for care 2. Patient is not eligible for HPV immunization Provider survey: Providers who are working at participating practices during the two times a crosssectional survey is administered. Parent survey: Parents of adolescents who presented for care within one 1 year prior to the two times a crosssectional survey is administration.</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>MCV4: Meningococcal Conjugate Vaccine</keyword>
	<keyword>HPV: Human Papillomavirus</keyword>
</DOC>